Sionna Therapeutics, Inc. (SION)
6.03
+0.16
(+2.73%)
USD |
NASDAQ |
Aug 31, 16:00
5.91
-0.12
(-1.99%)
After-Hours: 05:39
Sionna Therapeutics Cash from Operations (TTM) : -75.92M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -75.92M |
| March 31, 2026 | -71.85M |
| December 31, 2025 | -66.30M |
| September 30, 2025 | -61.45M |
| Date | Value |
|---|---|
| June 30, 2025 | -63.91M |
| March 31, 2025 | -55.90M |
| December 31, 2024 | -52.79M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Vertex Pharmaceuticals, Inc. | 4.293B |
| ACADIA Pharmaceuticals, Inc. | 160.32M |
| Immunic, Inc. | -87.72M |
| Alnylam Pharmaceuticals, Inc. | 885.89M |
| Anika Therapeutics, Inc. | 5.977M |